−98.3
Atrium Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−131
FY23:
57.1
FY24:
−22.1
FY25:
−41.1
Change from FY21 to FY24
millions USD
FY21:
−82.5
FY22:
−190
FY23:
−0.32
FY24:
−0.27
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
163
FY22:
345
FY23:
−56.1
FY24:
22.8
FY25:
42.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−98.6
FY22:
−139
FY23:
56.1
FY24:
−22.8
FY25:
−42.6
All amounts in millions USD